Abstract:
본 발명은 알파-글루코시다아제(α-glucosidase) 활성 저해물질인 1-데옥시노지리마이신 생합성에 관련된 폴리펩타이드, 이를 암호화하는 폴리뉴클레오티드, 상기 폴리뉴클레오티드를 포함하는 벡터, 상기 벡터를 포함하는 형질전환체, 및 상기 형질전환체를 이용하여 1-데옥시노지리마이신 합성관련 폴리펩타이드 또는 1-데옥시노지리마이신을 생산하는 방법에 관한 것이다. 본 발명의 폴리뉴클레오티드는 1-데옥시노지리마이신의 대량생산에 사용될 수 있으며, 또한, 재조합 기술을 이용하여 새로운 1-데옥시노지리마이신 유도체 탐색 연구에 사용될 수 있으므로, 당뇨환자를 위한 혈당강하제 및 병원성 바이러스 저해제 개발에 유용하다.
Abstract:
PURPOSE: A pharmaceutical composition containing alpha-glucosidaase inhibitors and beer yeast is provided to lower blood glucose after eating a meal and to enhance insulin in blood. CONSTITUTION: A pharmaceutical composition for preventing or treating diabetes contains alpha-glucosidase inhibitors and beer yeast as active ingredients. The alpha-glucosidase inhibitor is acarbose, voglibose and miglitol, soybean fermentation, soybean fermented extract, pine needle distiller concentrate, guava leaf extract, defatted Oenothera odorata JACQ. seed extract, banaba spirit extract, freeze-dried silkworm powder and inulin, a microorganism of Bacillus sp., Actinomycetes sp., Streptomyces sp., and Aspergillus niger sp., or a mixture thereof. [Reference numerals] (AA) Oral glucose tolerance test(OGTT); (BB) Blood glucose(mg/dl); (CC) Control group; (DD) Soybean fermentation; (EE) Mixture composition 2(soybean fermentation+beer yeast); (FF) 0 minute; (GG) 30 minutes; (HH) 60 minutes; (II) 120 minutes; (JJ) 180 minutes
Abstract:
본 발명은 알파-글루코시다아제 저해제 함유 조성물 및 맥주효모를 유효성분으로 포함하는, 당뇨병의 예방 또는 치료용 약학 조성물, 및 식품 첨가제에 관한 것으로, 본 발명의 약학 조성물 및 식품 첨가제는 식후 혈당을 크게 낮출 뿐만 아니라 지속적으로 섭취하였을 때 내당능, 당화혈색소, 혈중인슐린 등의 효능을 크게 증진시킬 수 있으므로 당뇨병을 예방 또는 치료하기 위한 다양한 건강기능식품 및 의약품에 유용하게 적용될 수 있다.
Abstract:
PURPOSE: A polypeptide for deoxynojirimycin(DNJ) synthesis is provided to produce a large amount of DNJs using a transformant and to develop an agent for reducing blood glucose. CONSTITUTION: An amino acid sequence for DNJ biosynthesis is denoted by sequence number 10. A nucleic acid molecule relating to DNJ biosynthesis is isolated from Bacillus subtilis sp. A recombinant vector contains the nucleic acid molecules. A host cell is transformed using the recombinant vector. The host cell is yeast, Bacillus subtilis or Escherichia coli. A method for producing polypeptides for DNJ biosynthesis comprises: a step of transforming the host cells with the recombinant vector; and a step of culturing the host cells to collect polypeptides.
Abstract:
PURPOSE: A polypeptide associated with deoxynojirimycin(DNJ) biosynthesis and a gene group encoding the same are provided to produce deoxynojirimycin derivatives and to develop a pathogenic virus inhibitor. CONSTITUTION: A deoxynojirimycin(DNJ) biosynthesis-associated protein has an amino acid sequence of sequence number 11. A nucleic acid molecule relating to DNJ biosynthesis contains: a) a base sequence encoding an amino acid sequence of sequence number 11; b) a base sequence which is complementary to the base sequence of a); or c) a base sequence which is hybridizable with the base sequence of a) or b).